Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HIMS vs GSK✓SelectedUSD · GSKHIMS vs GSK performance historyLatest closeAs of-8.86%11/20
Stock and ETF performance explorer

HIMS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+104.2%
GSK return
+40.7%
Excess return
+63.5%
Maximum drawdown
-78.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-8.9%-0.1%-8.7%-8.9%
7D-26.0%-5.3%-20.7%-25.6%
30D-50.0%-3.7%-46.4%-49.8%
3M-54.2%-7.3%-46.9%-53.8%
6M-36.6%-4.2%-32.4%-36.6%
YTD-55.0%+0.9%-55.9%-55.4%
1Y-56.6%+7.3%-63.8%-57.4%
3Y+88.6%+52.7%+35.9%+63.1%
All+104.2%+40.7%+63.5%+47.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling